Brief: Imprimisrx Announces Leadership Changes
06/10/2025 12:09
Oct 6 (Reuters) - Harrow Inc HROW.O: IMPRIMISRX ANNOUNCES LEADERSHIP CHANGES HARROW INC - FRANK MULLERY APPOINTED AS CEO OF IMPRIMISRX Source text: ID:nGNXbbYSH0 Further company coverage: HROW.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates